文献速递神经肿瘤

设施手术量对II级脑膜瘤全切除后总生存的影响

Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection.
PubMed 文献 · World Neurosurg · 2020-05-11

基于美国国家癌症数据库2823例II级脑膜瘤全切除患者,按设施手术量分层分析显示,手术量>8例/十年设施的5年OS为87.5%,≤8例/十年为72.8%(P<0.0001);全切除加辅助放疗与单纯全切除的5年OS无差异(84.8% vs. 86.4%;P=0.151)。

要点

  • 高手术量设施(>8例/十年)的5年OS显著优于低手术量设施(87.5% vs. 72.8%)。
  • 全切除后辅助放疗与单纯全切除的5年OS无统计学差异。
  • 设施位置、手术量、距离和肿瘤大小与辅助放疗的接受显著相关。

核心结论

  • 在较高手术量设施治疗与II级脑膜瘤全切除后更优的总生存相关。
  • 辅助放疗与单纯手术在全切除II级脑膜瘤患者中未观察到OS差异。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库识别2823例接受全切除的II级脑膜瘤患者。
  • 采用倾向性评分匹配平衡辅助放疗状态分组的协变量,多变量logistic回归评估放疗相关因素,Kaplan-Meier和log-rank检验评估按设施手术量的OS。

主要发现

  • 设施手术量≤8例/十年的5年OS为72.8%,>8例/十年为87.5%(P<0.0001)。
  • 全切除加辅助放疗与单纯全切除的5年OS分别为86.4%和84.8%(P=0.151)。
  • 与接受放疗显著相关的协变量包括设施位置、设施手术量、距离和肿瘤大小。

关键数值与推荐

  • 设施手术量分组阈值:≤8例/十年 vs. >8例/十年。
  • 5年OS:≤8例/十年组72.8%,>8例/十年组87.5%(P<0.0001)。
  • 5年OS:全切除+辅助放疗86.4% vs. 单纯全切除84.8%(P=0.151)。

临床怎么用

  • II级脑膜瘤全切除患者可优先考虑在高手术量设施治疗以改善总生存。
  • 全切除后辅助放疗对总生存的获益在本研究中未得到证实,需结合NRG-BN003等前瞻性 trial 结果综合决策。

局限性

  • 原文摘要未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of adjuvant radiation after gross total resection (GTR) for grade II meningioma is evolving, prompting further evaluation in NRG-BN003, a phase 3 national trial. Furthermore, the relationship between facility volume and outcomes in patients with grade II meningioma after GTR has not been examined at a national level. We aim to assess overall survival (OS) of patients with grade II meningioma after GTR by surgical case volume and OS by receipt of adjuvant radiation. METHODS: We used the National Cancer Database to identity 2823 patients diagnosed with grade II meningioma who underwent GTR. Propensity score matching was applied to balance covariates in patients with grade II meningioma after GTR stratified by adjuvant radiation status. Multivariable logistic regression was used to assess factors associated with radiation receipt. Kaplan-Meier and log-rank tests were used to assess OS by facility volume. RESULTS: As facility volume increased, OS increased, with a 5-year OS of 72.8% for facilities with GTR grade II meningioma volumes of ≤8 cases per decade and 87.5% for >8 cases per decade (P < 0.0001). There was no difference in 5-year OS between GTR alone and GTR with adjuvant radiation (84.8% vs. 86.4%; P = 0.151). Covariates significantly associated with radiation receipt included facility location, facility volume, distance, and tumor size. CONCLUSIONS: Treatment at higher surgical case volume facilities is associated with improved OS for GTR grade II meningioma. These facilities also have more patients receiving adjuvant radiation. However, we observed no difference in OS between adjuvant radiation and surgery alone.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Anakwenze CP, McGovern S, Taku N, et al. Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg. 2020. PMID: 32407910. doi:10.1016/j.wneu.2020.05.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。